MX2008008639A - Dermatological viscoelastic gel - Google Patents
Dermatological viscoelastic gelInfo
- Publication number
- MX2008008639A MX2008008639A MX/A/2008/008639A MX2008008639A MX2008008639A MX 2008008639 A MX2008008639 A MX 2008008639A MX 2008008639 A MX2008008639 A MX 2008008639A MX 2008008639 A MX2008008639 A MX 2008008639A
- Authority
- MX
- Mexico
- Prior art keywords
- polysaccharide
- gel
- hyaluronic acid
- glycerol
- aqueous solution
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 45
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 25
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 22
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 22
- 239000000243 solution Substances 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 150000004676 glycans Chemical class 0.000 claims abstract description 17
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 17
- 239000005017 polysaccharide Substances 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 9
- 239000002671 adjuvant Substances 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 239000005022 packaging material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 8
- 230000003716 rejuvenation Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
- 229940099552 hyaluronan Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000000694 mesotherapy Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Abstract
The invention relates to a natural dermatological polysaccharide gel comprising a polysaccharide aqueous solution whose weight/volume ratio ranges from 0.1 to 5%, for, example a hyaluronic acid, and a biocompatible viscous highly-hydrophilic alcohol whose weight/volume ratio ranges from 0.5 to 5%, for example a glycerol, and, possibly, adjuvants used in dermatology. The inventive gel is prepared by mixing the polysaccharide solution and the viscous highly-hydrophilic alcohol prior to sterilising the totality for example by wet heat.
Description
VISCOELASTIC GEL FOR DERMATOLOGICAL USE DESCRIPTION OF THE INVENTION The invention is concerned with a viscoelastic gel for dermatological use. Several polymers of natural origin such as collagen, hyaluronic acid or cellulose derivatives are frequently used in aesthetic medicine and in dermatology to fill wrinkles, reshape the face, increase the volume of lips and rejuvenate the skin of the face; This last type of treatment is directly derived from mesotherapy. To rejuvenate the skin, doctors often use hyaluronic acid, sometimes combined with a complex of vitamins, amino acids, mineral salts and nucleic acids. The object of this invention consists of the combination of a polysaccharide of natural origin, more particularly hyaluronan and a viscous alcohol to propose a composition prepared for injectable use that optimizes the treatment of skin rejuvenation, in particular involving a polysaccharide gel of natural origin that is used as an injection in dermatology, comprising an aqueous solution of polysaccharide at 0.1 - 5% w / v and a viscous and strongly hydrophilic biocompatible alcohol at 0.5 - 5% w / v, obtained by preparation of an aqueous solution of the polysaccharide and alcohol, then sterilization of this solution and optionally the adjuvants which are commonly used in dermatology, sterilization after the mixing of the components which has the effect of considerably increasing the viscosity of the resulting gel. The combination of a polysaccharide or its salts, in particular hyaluronan or sodium hyaluronate, has now been found and a small amount of a biocompatible viscous alcohol provides a composition whose viscosity increases extensively, and which when the biocompatible viscous alcohol is also hydrophilic, considerably increases the water retention properties when the composition is injected under the skin to be treated. A hydrophilic compound is defined as any compound that has a strong affinity for water. In an alcohol, the higher the density of OH groups, the more hydrophilic it is. For example, glycerol, low molecular weight alcohol (92.09 g.mol) and containing three OH groups, is extremely hydrophilic. It has been found that the addition of a small amount, of the order of 0.5 to 5% w / v, of a viscous biocompatible alcohol effects a significant increase in the viscosity of a polysaccharide solution of natural origin at 0.1-5% by weight / volume, stabilizes this solution during sterilization and maintains particularly advantageous viscous properties for skin tissue rejuvenation. The viscous alcohol can participate in the restructuring of the skin and the maturation of cells of this tissue and ensures the isotonicity of the mixture. A biocompatible alcohol having antiseptic properties, which reduces this risk of skin infections, is preferably used. Actually, this risk is significant during a rejuvenation treatment, taking into account the large number of injections performed on the face. Examples of such alcohols are in particular glycerol and polyethylene glycol lauryl sulfate. Commercial hyaluronic acids have different molecular weights (MW) and different concentrations according to the manufacturer. By way of illustration, it is possible to use a concentration of 1.8% weight / volume for hyaluronic acid of low to medium weight (0.5 to 1.8 MDa) and a concentration of 1.5% weight / volume for high weight hyaluronic acid (2.0 to 3.0 MDa). The invention also provides a process for the preparation of a polysaccharide gel of natural origin for dermatological use, comprising the steps consisting of: (a) Preparing an aqueous solution of polysaccharide and viscous and strongly hydrophilic alcohol in the desired proportions, (b) Sterilize the resulting solution, in particular by moist heat, and (c) Optionally put the gel in a ready-for-use form. Figures 1 to 3 are graphs showing the viscosities of the compositions of Examples 1 and 2 according to the invention and Example 3 (by comparison). Example 1: Influence of the concentration of hyaluronic acid and the presence of glycerol on the viscosity of solutions for the rejuvenation of the face. Three solutions based on the same hyaluronic acid which is characterized by an average molecular weight of 1.6 MDa were prepared. The first solution is a 1% hyaluronic acid solution. The second solution is a solution of the same hyaluronic acid, but concentrated at 2%. The third solution contains only 1.8% of this same hyaluronic acid to which 2% w / v glycerol is added. The three preparations were sterilized by moist heat, then their rheological properties were analyzed using a rheometer to measure the viscosity based on the shear rate disposed on the product. It is clearly seen that, according to the graph of Figure 1, for the low shear rates (corresponding to those to which the preparation is exposed for skin tissue rejuvenation after injection), the addition of glycerol to a solution of hyaluronic acid has more influence to obtain a preparation of high viscosity than the increase in the concentration of hyaluronic acid. Example 2: Influence of glycerol on the viscosity of solutions of hyaluronic acid with high molecular weight. Two solutions based on hyaluronic acid, characterized by a very high average molecular weight (2.6 MDa) were prepared. The first preparation is a 1.5% hyaluronic acid solution. The second preparation also contains 1.5% hyaluronic acid with high molecular weight to which 2% w / v glycerol is added. The two preparations were sterilized by moist heat, then their rheological properties were analyzed using a rheometer to measure the viscosity based on the shear rate imposed on the product. The graph of Figure 2 demonstrates that, although the preparation consists of a high molecular weight hyaluronic acid - hence characterized initially by a high viscosity - the glycerol itself tends to increase the viscous properties of the product. Example 3: Stabilization of the preparation by glycerol during sterilization (by comparison). A solution was prepared with 1.5% hyaluronic acid, characterized by a very high average molecular weight (2.6 MDa). This solution was then sterilized by moist heat (preparation 1). Glycerol was added to several milliliters of this sterilized solution (preparation 2). No rheological difference was observed between these two preparations; The graph of Figure 3 and the examples presented above demonstrate the stabilizing effect of glycerol during sterilization. Therefore, it is essential that the viscous alcohol be mixed with the hyaluronic acid solution before sterilization to obtain the increase in viscosity. After sterilization, the composition can be put into a form ready for use, for example in an ampoule or vial containing the dose to be injected by means of a syringe. The composition may comprise adjuvants that are commonly used in dermatology, added to the mixture before sterilization. Such adjuvants are vitamins, mineral acids, mineral salts and nucleic acids.
Claims (6)
- CLAIMS 1. A polysaccharide gel of natural origin that is used for injection in dermatology, characterized in that it comprises an aqueous solution of polysaccharide at 0.1 - 5% w / v, and a viscous and strongly hydrophilic biocompatible alcohol at 0.5 - 5% in weight / volume, obtained by preparing an aqueous solution of the polysaccharide and alcohol, then sterilizing this solution, and optionally the adjuvants that are commonly used in dermatology, whereby sterilization after mixing of the components has the effect of increase appreciably the viscosity of the resulting gel.
- 2. The gel according to claim 1, characterized in that the polysaccharide is hyaluronic acid.
- 3. The gel according to claim 1 or 2, characterized in that the biocompatible alcohol is glycerol. The one according to any of claims 1 to 3, characterized in that the aqueous solution contains 1.8% w / v hyaluronic acid of average MW (0.5 to 1.8 MDa) and 2% w / v glycerol. The gel according to any of claims 1 to 3, characterized in that the aqueous solution contains 1.5% w / v of high PM hyaluronic acid (2.0 to 3.0 MDa) and 2% w / v glycerol.6. A process for the preparation of a polysaccharide gel of natural origin for dermatological use according to any of claims 1 to 3, characterized in that the steps consisting of: (a) Prepare an aqueous solution of polysaccharide and viscous biocompatible alcohol and strongly hydrophilic in the desired proportions, (b) Sterilize the resulting solution, in particular by moist heat, and (c) Optionally put the gel in a ready-to-use form.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0600138 | 2006-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008008639A true MX2008008639A (en) | 2008-10-03 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9468779B2 (en) | Viscoelastic gel for dermatological use | |
| EP2861626B1 (en) | Method of preparing a composition based on hyaluronic acid | |
| CA2923742C (en) | Method for obtaining an injectable hydrogel based on hyaluronic acid containing lidocaine added in powder form, and an alkaline agent, sterilized with heat | |
| US9402799B2 (en) | Sterilized composition comprising at least one hyaluronic acid and magnesium ascorbyl phosphate | |
| AU2013344659B2 (en) | Stable thermolysin hydrogel | |
| WO2017131130A1 (en) | Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid | |
| JP2016169188A (en) | Skin external preparation | |
| CN112351777A (en) | External composition | |
| JP2009510087A (en) | Stable ascorbic acid composition | |
| MX2008008639A (en) | Dermatological viscoelastic gel | |
| JP2020534295A (en) | Topical composition containing crosslinked hyaluronic acid and polyacrylate compound | |
| EP3126008B1 (en) | In vivo degradation of polysaccharide-containing fillers | |
| KR102329495B1 (en) | Biodegradable polymer for administrating to a living body or for cosmetic surgery containing sodium 2-mercaptoethane sulfonate as an osmotic agent | |
| CA3162064A1 (en) | Injectable mixtures of hyaluronic acid for use in dermo-aesthetics | |
| HK40045236A (en) | External-use composition | |
| HK1224550A1 (en) | Method for obtaining an injectable hydrogel based on hyaluronic acid containing lidocaine added in powder form, and an alkaline agent, sterilized with heat |